Business Day TV spoke to Peter Wharton-Hood, CEO of Life Healthcare
Shareholders receive huge payout as the company drives strong annual earnings growth
Business Day TV speaks to Richard Friedland after Netcare posted a 15.8% rise in annual profit
Public-private partnerships could offer quicker fix to SA’s healthcare woes than NHI, says CEO
Business Day TV speaks to Stavros Nicolaou, a senior executive at Aspen
The listing of 3.25-billion ordinary shares gives the company an anticipated market cap of about R30bn
Better supply chain visibility expected to reassure US drug makers products will reach intended destination
The drugmaker will spend $2bn on research & development and on plants that manufacture biologics medicines and cell therapies
The sublicensing of LMI's RM2 product contributed about R430m to earnings
Drugmaker says Chinese authorities haven’t given reasons for apprehending Leon Wang
Agreement positions pharmaceutical firm to tap into lucrative sector driven by global demand
Though under pressure from activist investor Starboard, Pfizer has topped third-quarter estimates
Business Day TV speaks with Rui Morais, CEO of Dis-Chem
Medical scheme mum on why contract with ADS was terminated and handed to its former CEO
Sales of the drugmaker’s oncology drugs rose nearly 19% worldwide for the quarter, driven by sales of its cancer treatment Darzalex
Starboard Value has approached a former CEO and CFO, both of whom have expressed interest, sources say
Bestmed flags rise in fraudulent activities including practitioners claiming services for dead people
Private healthcare provider on track to meet its full-year guidance and strategic project goals
Prices top inflation as demand grows and few young people join medical schemes
J&J faces lawsuits from more than 62,000 claimants who alleged that its talc products were contaminated with asbestos